Holistic Philosophy: We consider underlying metabolic, hormonal, and lifestyle factors to support long-term change, not just a number on the scale
Therefore, as delivery technologies continue to evolve, they are expected to differentiate GLP-1 therapies in an increasingly competitive sector
Epidemiology and risk factors for IBD
CrossRef The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature Helen Ye Rim Huang, Sarah Badar, Mohammad Said, Siddiqah Shah, Hareesha Rishab Bharadwaj, Krishna Ramamoorthy, Maen Monketh Alrawashdeh, Faaraea Haroon, Jawad Basit, Sajeel Saeed, Narjiss Aji, Gary Tse, Priyanka Roy, Mainak Bardhan Molecular Biology Reports.2024;[Epub] CrossRef The complex interplay between oxinflammation, mitochondrial dysfunction and lipotoxicity: Focus on their role in the pathogenesis of skeletal muscle insulin resistance and modulation by dietary fatty acids Angelina Passaro, Juana Maria Sanz, Nenad Naumovski, Domenico Sergi Advances in Redox Research.2024
Late bookings available
These include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or history of pancreatitis
